<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter" xml:lang="EN">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title>Emerging Infectious Diseases</journal-title>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">19046536</article-id>
      <article-id pub-id-type="pmc">2634623</article-id>
      <article-id pub-id-type="publisher-id">08-0494</article-id>
      <article-id pub-id-type="doi">10.3201/eid1412.080494</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Human <italic>Salmonella</italic> Infection Yielding CTX-M &#x3B2;-Lactamase, United States</article-title>
        <alt-title alt-title-type="running-head">Human <italic>Salmonella</italic> Infection Yielding CTX-M &#x3B2;-Lactamase, United States</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Sj&#xF6;lund</surname>
            <given-names>Maria</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yam</surname>
            <given-names>Jennifer</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schwenk</surname>
            <given-names>Jillian</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Joyce</surname>
            <given-names>Kevin</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Medalla</surname>
            <given-names>Felicita</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barzilay</surname>
            <given-names>Ezra</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Whichard</surname>
            <given-names>Jean M.</given-names>
          </name>
        </contrib>
        <aff id="aff1">Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Sj&#xF6;lund, J. Yam, J. Schwenk, K. Joyce, F. Medalla, E. Barzilay, J.M. Whichard)</aff>
        <aff id="aff2">Atlanta Research and Education Foundation, Atlanta (M. Sj&#xF6;lund, J. Yam, K. Joyce)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Maria Sj&#xF6;lund, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop G29, Atlanta GA 30333, USA; email: <email xlink:href="fwt4@cdc.gov">fwt4@cdc.gov</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2008</year>
      </pub-date>
      <volume>14</volume>
      <issue>12</issue>
      <fpage>1957</fpage>
      <lpage>1959</lpage>
      <kwd-group kwd-group-type="author" xml:lang="EN">
        <title>Keywords: </title>
        <kwd>Salmonella</kwd>
        <kwd>antimicrobial drug resistance</kwd>
        <kwd>CTX-M-5 beta-lactamase</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> In the United States most third-generation cephalosporin resistance among salmonellae is due to AmpC plasmid&#x2013;mediated &#x3B2;-lactamases. Extended-spectrum &#x3B2;-lactamases (ESBLs) have rarely been reported (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). The CTX-M &#x3B2;-lactamases constitute a group of ESBL enzymes that are increasing in prevalence worldwide. Currently, the CTX-M enzymes are classified into 5 different subgroups on the basis of DNA sequence similarities (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). We report on a domestically acquired CTX-M&#xAD;&#x2013;producing <italic>Salmonella</italic> isolate in the United States.</p>
    <p>In 2003, public health laboratories in all US state health departments submitted every 20th non-Typhi <italic>Salmonella</italic> (NTS) isolate from humans to the Centers for Disease Control and Prevention (CDC) for susceptibility testing by the National Antimicrobial Resistance Monitoring System (NARMS). MICs were determined by broth microdilution and interpreted according to Clinical and Laboratory Standards Institute standards (<ext-link ext-link-type="uri" xlink:href="http://www.clsi.org">www.clsi.org</ext-link>), when available. Resistance to cefquinome was defined as <underline>&gt;</underline>32 mg/L.</p>
    <p>Among the 1,864 human NTS isolates submitted to NARMS in 2003, 105 (5.6%) displayed elevated MICs (<underline>&gt;</underline>2 mg/L) to ceftriaxone or ceftiofur, third-generation cephalosporins used in human and veterinary medicine, respectively. Genomic DNA was prepared from the 105 isolates, and a PCR with degenerate primers capable of detecting all CTX-M enzymes identified a single positive <italic>S. enterica</italic> ser. Typhimurium (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). The isolate came from a stool sample collected in September 2003 from a white, non-Hispanic, US-born, 3-month-old boy who lived in the state of Georgia. The patient had diarrhea and fever for &#x2248;1 week. Because neither the patient nor his family had traveled internationally in the 3 months before specimen collection, the infection appears to have been domestically acquired. The patient did not receive any antimicrobial agents before illness but was treated for 14 days with cefpodoxime. The infant recovered from the illness without complications.</p>
    <p>The isolate displayed resistance to &#x3B2;-lactams, aminoglycosides, phenicols, tetracyclines, and folate pathway inhibitors (<xref ref-type="table" rid="T1">Table</xref>). Two &#x3B2;-lactamases (isoelectric pH [pI] 7.5 and 8.8) were resolved by isoelectric focusing.</p>
    <table-wrap id="T1" position="float">
      <label>Table</label>
      <caption>
        <title>MIC values of antimicrobial drugs for the <italic>Salmonella</italic> ser. Typhimurium isolate and its <italic>Escherichia coli</italic> DH10B transformant</title>
      </caption>
      <table frame="hsides" rules="groups">
        <col width="122" span="1"/>
        <col width="60" span="1"/>
        <col width="90" span="1"/>
        <col width="43" span="1"/>
        <thead>
          <tr>
            <th rowspan="2" valign="bottom" align="left" scope="col" colspan="1">Antimicrobial agent</th>
            <th valign="bottom" colspan="3" align="center" scope="colgroup" rowspan="1">MIC, mg/L<hr/></th>
          </tr>
          <tr>
            <th valign="bottom" colspan="1" align="center" scope="colgroup" rowspan="1"><italic>S.</italic> ser. Typhimurium</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1"><italic>E. coli</italic> DH10B transformant</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1"><italic>E. coli</italic> DH10B</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Amikacin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Amoxicillin&#x2013;clavulanic acid</td>
            <td valign="top" align="center" rowspan="1" colspan="1">32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">16</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ampicillin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Aztreonam</td>
            <td valign="top" align="center" rowspan="1" colspan="1">32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.12</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefepime</td>
            <td valign="top" align="center" rowspan="1" colspan="1">32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">32</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.06</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefotaxime</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.06</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefotaxime&#x2013;clavulanic acid</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.25</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.12</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.06</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefoxitin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2</td>
            <td valign="top" align="center" rowspan="1" colspan="1">8</td>
            <td valign="top" align="center" rowspan="1" colspan="1">8</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefquinome</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.06</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ceftazidime</td>
            <td valign="top" align="center" rowspan="1" colspan="1">8</td>
            <td valign="top" align="center" rowspan="1" colspan="1">8</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.5</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ceftazidime&#x2013;clavulanic acid</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.5</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.25</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.12</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ceftiofur</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;8</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;8</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.5</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ceftriaxone</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.25</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chloramphenicol</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>2</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>2</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ciprofloxacin</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.016</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.016</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.016</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gentamicin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.25</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.25</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Imipenem</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.5</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.25</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.25</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kanamycin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>8</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>8</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nalidixic acid</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Piperacillin-tazobactam</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Streptomycin</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;64</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sulfisoxazole</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>16</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>16</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tetracycline</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>4</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>4</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Trimethoprim-sulfamethoxazole</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;4</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.12</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.12</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <p>Group-specific PCR primers were used to characterize the presumed <italic>bla</italic><sub>CTX-M</sub> gene (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). Primers TOHO1&#x2013;2F and TOHO1&#x2013;1R yielded a 351-bp product, confirming a group II <italic>bla</italic><sub>CTX-M</sub> gene. To perform sequencing of the entire gene, a ClustalW alignment with representatives from group II was performed to identify primers (DNASTAR, Madison, WI, USA). The sequence of the gene was identical to the sequence of the <italic>bla</italic><sub>CTX-M-5</sub> gene detected in other isolates of <italic>S. enterica</italic> ser. Typhimurium (GenBank accession nos. U95364 and AF286192) as well as to the <italic>kluA-2</italic> gene of <italic>Kluyvera ascorbata</italic> (GenBank accession no. AJ251722).</p>
    <p>The genetic environment of the <italic>bla</italic><sub>CTX-M-5</sub> gene was investigated by PCR specific for upstream insertion elements (IS<italic>Ecp1</italic>, IS<italic>26</italic>, and ORF513) and the downstream sequence <italic>sul1</italic> (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>). Amplification with primer IS<italic>Ecp1</italic> and an internal <italic>bla</italic><sub>CTX-M-5</sub> primer yielded a PCR product of &#x2248;350 bp. Sequencing confirmed presence of the 3&#x2032; end inverted repeat region of the IS<italic>Ecp1</italic>.</p>
    <p>Presence of other &#x3B2;-lactamase&#x2013;encoding genes (<italic>bla</italic><sub>TEM</sub>, <italic>bla</italic><sub>SHV</sub>, and <italic>bla</italic><sub>OXA</sub>) was investigated by PCR (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>&#x2013;<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). Amplification with primers OXA-1F and OXA-1R yielded a 595-bp product with a sequence consistent with that of <italic>bla</italic><sub>OXA-1</sub> (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>).</p>
    <p>To determine whether the CTX-M enzyme was plasmid-borne, plasmids were extracted and transformed into electrocompetent <italic>Escherichia coli</italic> DH10B. The transformant exhibited resistance to cefotaxime but not to ceftazidime (<xref ref-type="table" rid="T1">Table</xref>). In addition, the transformant exhibited resistance to cefquinome and cefepime. The presence of a <italic>bla</italic><sub>CTX-M</sub> gene was confirmed by PCR (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>,<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). The <italic>bla</italic><sub>OXA</sub> gene could not be amplified from the <italic>E. coli</italic> transformant (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>).</p>
    <p>A CTX-M&#x2013;producing <italic>Salmonella</italic> isolate has been reported only once previously in the United States (<xref ref-type="bibr" rid="R9"><italic>9</italic></xref>). This was in 1994, when an isolate of <italic>Salmonella</italic> ser. Typhimurium var. Copenhagen with a CTX-M-5 was recovered from a 4-month-old girl adopted from Russia; that infection was not domestically acquired (<xref ref-type="bibr" rid="R9"><italic>9</italic></xref>). We compared the 1994 isolate and the isolate in this study by pulsed-field gel electrophoresis; the isolates showed distinct patterns.</p>
    <p>The IS<italic>Ecp1</italic> insertion sequence has been described as a flanking region of several <italic>bla</italic><sub>CTX-M</sub> genes and has been implicated in the expression and mobilization of the genes (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>). A recent study by Lartigue et al. showed that a CTX-M-2 progenitor in <italic>K. ascorbata</italic> could be mobilized and transferred to a conjugative <italic>E. coli</italic> plasmid by the IS<italic>Ecp1B</italic> element; enhanced mobilization was observed in the presence of ceftazidime, cefotaxime, and piperacillin (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>).</p>
    <p>This <italic>Salmonella</italic> isolate&#x2019;s resistance to cefepime and cefquinome, fourth-generation cephalosporins, is troubling. Cefquinome is not approved for use in the United States but has been used in Europe for treating food animals since 1994. ESBLs, including CTX-M enzymes, are more common in Europe than in the United States (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). Further studies are warranted to clarify the extent to which the use of cefquinome has contributed to high CTX-M prevalence in Europe.</p>
    <p>In conclusion, we report a domestically acquired CTX-M&#x2013;producing <italic>Salmonella</italic> isolate in the United States. Because third-generation cephalosporins are important for treating invasive <italic>Salmonella</italic> infections, continued monitoring of ESBL-producing bacteria is important.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Sj&#xF6;lund M, Yam J, Schwenk J, Joyce K, Medalla F, Barzilay E, et al. Human <italic>Salmonella</italic> infection yielding CTX-M &#x3B2;-lactamase, United States [letter]. Emerg Infect Dis [serial on the Internet]. 2008 Dec [<italic>date cited</italic>]. Available from <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/EID/content/14/12/1957.htm">http://www.cdc.gov/EID/content/14/12/1957.htm</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank the NARMS-participating public health laboratories for submitting isolates, Matt Mikoleit for confirming the <italic>Salmonella</italic> serotype, Anne Whitney for DNA sequencing, and the Georgia Division of Public Health for providing patient interview information.</p>
      <p>This work was supported by an interagency agreement between CDC and the Food and Drug Administration Center for Veterinary Medicine.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <citation citation-type="journal"><string-name><surname>Bush</surname> <given-names>K</given-names></string-name> <article-title>Extended-spectrum beta-lactamases in North America, 1987&#x2013;2006.</article-title><source>Clin Microbiol Infect</source> <year>2008</year>;<volume>14</volume>(<issue>Suppl 1</issue>):<fpage>134</fpage>&#x2013;<lpage>43</lpage> <pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01848.x</pub-id><pub-id pub-id-type="pmid">18154537</pub-id></citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <citation citation-type="journal"><string-name><surname>Bonnet</surname> <given-names>R</given-names></string-name> <article-title>Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.</article-title><source>Antimicrob Agents Chemother</source> <year>2004</year>;<volume>48</volume>:<fpage>1</fpage>&#x2013;<lpage>14</lpage> <pub-id pub-id-type="doi">10.1128/AAC.48.1.1-14.2004</pub-id><pub-id pub-id-type="pmid">14693512</pub-id></citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <citation citation-type="journal"><string-name><surname>Bonnet</surname> <given-names>R</given-names></string-name>, <string-name><surname>Recule</surname> <given-names>C</given-names></string-name>, <string-name><surname>Baraduc</surname> <given-names>R</given-names></string-name>, <string-name><surname>Chanal</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sirot</surname> <given-names>D</given-names></string-name>, <string-name><surname>De Champs</surname> <given-names>C</given-names></string-name>, <etal/><article-title>Effect of D240G substitution in a novel ESBL CTX-M-27.</article-title><source>J Antimicrob Chemother</source> <year>2003</year>;<volume>52</volume>:<fpage>29</fpage>&#x2013;<lpage>35</lpage> <pub-id pub-id-type="doi">10.1093/jac/dkg256</pub-id><pub-id pub-id-type="pmid">12775683</pub-id></citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <citation citation-type="journal"><string-name><surname>Pitout</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Hossain</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hanson</surname> <given-names>ND</given-names></string-name> <article-title>Phenotypic and molecular detection of CTX-M-beta-lactamases produced by <italic>Escherichia coli</italic> and <italic>Klebsiella</italic> spp.</article-title><source>J Clin Microbiol</source> <year>2004</year>;<volume>42</volume>:<fpage>5715</fpage>&#x2013;<lpage>21</lpage> <pub-id pub-id-type="doi">10.1128/JCM.42.12.5715-5721.2004</pub-id><pub-id pub-id-type="pmid">15583304</pub-id></citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <citation citation-type="journal"><string-name><surname>Eckert</surname> <given-names>C</given-names></string-name>, <string-name><surname>Gautier</surname> <given-names>V</given-names></string-name>, <string-name><surname>Saladin-Allard</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hidri</surname> <given-names>N</given-names></string-name>, <string-name><surname>Verdet</surname> <given-names>C</given-names></string-name>, <string-name><surname>Ould-Hocine</surname> <given-names>Z</given-names></string-name>, <etal/><article-title>Dissemination of CTX-M&#x2013;type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France.</article-title><source>Antimicrob Agents Chemother</source> <year>2004</year>;<volume>48</volume>:<fpage>1249</fpage>&#x2013;<lpage>55</lpage> <pub-id pub-id-type="doi">10.1128/AAC.48.4.1249-1255.2004</pub-id><pub-id pub-id-type="pmid">15047527</pub-id></citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <citation citation-type="journal"><string-name><surname>Brinas</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zarazaga</surname> <given-names>M</given-names></string-name>, <string-name><surname>Saenz</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ruiz-Larrea</surname> <given-names>F</given-names></string-name>, <string-name><surname>Torres</surname> <given-names>C</given-names></string-name> <article-title>Beta-lactamases in ampicillin-resistant <italic>Escherichia coli</italic> isolates from foods, humans, and healthy animals.</article-title><source>Antimicrob Agents Chemother</source> <year>2002</year>;<volume>46</volume>:<fpage>3156</fpage>&#x2013;<lpage>63</lpage> <pub-id pub-id-type="doi">10.1128/AAC.46.10.3156-3163.2002</pub-id><pub-id pub-id-type="pmid">12234838</pub-id></citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <citation citation-type="journal"><string-name><surname>Rasheed</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Jay</surname> <given-names>C</given-names></string-name>, <string-name><surname>Metchock</surname> <given-names>B</given-names></string-name>, <string-name><surname>Berkowitz</surname> <given-names>F</given-names></string-name>, <string-name><surname>Weigel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Crellin</surname> <given-names>J</given-names></string-name>, <etal/><article-title>Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of <italic>Escherichia coli</italic> during multiple episodes of bacteremia.</article-title><source>Antimicrob Agents Chemother</source> <year>1997</year>;<volume>41</volume>:<fpage>647</fpage>&#x2013;<lpage>53</lpage><pub-id pub-id-type="pmid">9056008</pub-id></citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <citation citation-type="journal"><string-name><surname>Chen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>S</given-names></string-name>, <string-name><surname>White</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Schroeder</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>R</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>H</given-names></string-name>, <etal/><article-title>Characterization of multiple-antimicrobial&#x2013;resistant salmonella serovars isolated from retail meats.</article-title><source>Appl Environ Microbiol</source> <year>2004</year>;<volume>70</volume>:<fpage>1</fpage>&#x2013;<lpage>7</lpage> <pub-id pub-id-type="doi">10.1128/AEM.70.1.1-7.2004</pub-id><pub-id pub-id-type="pmid">14711619</pub-id></citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <citation citation-type="confproc"><string-name><surname>Zirnstein</surname> <given-names>G</given-names></string-name>, <string-name><surname>Swaminathan</surname> <given-names>B</given-names></string-name>, <string-name><surname>Angulo</surname> <given-names>F</given-names></string-name>, <string-name><surname>Tenover</surname> <given-names>F</given-names></string-name>, <string-name><surname>Rasheed</surname> <given-names>JK</given-names></string-name> Plasmid-mediated CTX-M-5 &#x3B2;-lactamase conferring resistance to ceftriaxone and cefotaxime in a <italic>Salmonella</italic> serotype Typhimurium var. Copenhagen isolate from an infant adopted from Russia. In: Proceedings of the 2nd International Conference on Emerging Infectious Diseases, Atlanta, Georgia, USA. July 16&#x2013;19, 2000. Washington: American Society for Microbiology; <year>2000</year></citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <citation citation-type="journal"><string-name><surname>Lartigue</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Poirel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Aubert</surname> <given-names>D</given-names></string-name>, <string-name><surname>Nordmann</surname> <given-names>P</given-names></string-name> <article-title>In vitro analysis of ISEcp1B-mediated mobilization of naturally occurring beta-lactamase gene <italic>bla</italic><sub>CTX-M</sub> of <italic>Kluyvera ascorbata.</italic></article-title><source>Antimicrob Agents Chemother</source> <year>2006</year>;<volume>50</volume>:<fpage>1282</fpage>&#x2013;<lpage>6</lpage> <pub-id pub-id-type="doi">10.1128/AAC.50.4.1282-1286.2006</pub-id><pub-id pub-id-type="pmid">16569841</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
